The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined alternating sunitinib and bevacizumab in the management of advanced renal cell carcinoma: A phase I/II trial.
 
Shouki Bazarbashi
Honoraria - Bayer; Bristol-Myers Squibb; Lilly; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Merck Sharp & Dohme; pfizer; Roche
Research Funding - Lilly
Travel, Accommodations, Expenses - Janssen; Merck; SERVIER
 
Ahmed M Alzahrani
No Relationships to Disclose
 
Ali H Aljubran
Honoraria - Bayer
Speakers' Bureau - Bayer; Ipsen; SERVIER
Travel, Accommodations, Expenses - SERVIER
 
Mahmoud Abdelsatar Elshenawy
No Relationships to Disclose
 
Ahmed Mostafa Gad
No Relationships to Disclose
 
Fatma Maraiki
No Relationships to Disclose
 
Noura Alzannan
No Relationships to Disclose
 
Tusneem Elhassan
No Relationships to Disclose
 
Ahmed Ali Badran
No Relationships to Disclose